300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
EdTech
Hospitality
Consumer
Artificial Intelligence
Local
Platforms
Travel
Enterprise Software
InsurTech
Cryptocurrency
Oil and Gas
Retail
Social Impact
SaaS
Film
Restaurants
Payments
Photography
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Blockchain
Facebook
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Software
Crowdfunding
Venture Capital
Theatre
Recruiting
Web3
Medical
Fashion
LGBT
Beauty
Social
Infrastructure
Mobile Apps
Wine and Spirits
Food and Beverage
Publishing
Life Science
Cannabis
Climate
Music
Celebrity
Digital Media
FinTech
Manufacturing
Sporting Goods
Finance
Financial Services
Social Media
Real Estate
Franchise
Mobile Advertising
Non Profit
Internet
Art
Android
Biotech
Sustainability
Enterprise
Transportation
Proptech
Impact
Community
Hardware
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Gibraltar
Brazil
Egypt
Kyrgyzstan
Zambia
Singapore
Zimbabwe
Sweden
Oceania
Taiwan
LATAM
Norway
Liberia
Tajikistan
Tunisia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Isle of Man
Iran
Madagascar
Pakistan
Romania
Lesotho
Guernsey
Oman
Poland
Puerto Rico
Cameroon
Andorra
Sudan
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mauritius
Mozambique
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
Ireland
South Africa
France
Georgia
Ghana
Denmark
Iraq
Latvia
Mali
Malaysia
Rwanda
Philippines
Portugal
Sierra Leone
Senegal
El Salvador
Tanzania
India
United States
Germany
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Argentina
Bangladesh
Spain
Barbados
Belgium
Angola
Europe
Austria
Ethiopia
Jordan
Cyprus
Azerbaijan
Bulgaria
Ecuador
Estonia
Bolivia
Belize
Algeria
Italy
Faroe Islands
Jersey
Finland
Bahrain
Belarus
Hungary
Bahamas
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
BMI KOREA, VC Fund

BMI KOREA

VC Fund

Jeju, South Korea

BMI KOREA is a VC fund in Jeju focused on Medical and Biotechnology. BMI KOREA engages in the production of pharmaceutical products and medical devices.

Total investments:
3
Last investment:
Lead investor:
0%

Last updated:

Industries BMI KOREA invests in

MedicalBiotechnologyPharmaceuticalHealth CareTherapeutics

Stages BMI KOREA invests in

Series BSeed

Countries BMI KOREA invests in

South Korea

Investment Focus

Industry

  • Medical 3 (100%)
  • Biotechnology 2 (67%)
  • Pharmaceutical 2 (67%)
  • Health Care 1 (33%)
  • Therapeutics 1 (33%)

Stage

  • Series B 2 (67%)
  • Seed 1 (33%)

Investments

CompanyDescriptionRoundLinks
CrossPoint Therapeutics CrossPoint Therapeutics
CrossPoint Therapeutics is a therapeutics company that specializes in drug development by using Stealth-Body with antibody source technology. $2.5M / Seed / Mar 04, 2026
Mitoimmune Therapeutics Mitoimmune Therapeutics
Mito Immune Therapeutics is a drug research and development biotech company. $3.9M / Series B / Sep 21, 2023
MetaFines MetaFines
MetaFines is a biopharma firm that creates anticancer medications with the goal of preventing the spread of cancer. By extending and reconfiguring the indications of off-label medications for terminal tumors, the company creates minimal anticancer pharmaceuticals. It also provides subcutaneous injections and therapies, allowing patients to fightcancer and enhance their standard of living with cancer metabolism.The company develops ow-toxic medicines for metabolic cancer. This low-toxic metabolic anti-cancer agent is distinguished by being created so that metabolic anti-cancer agents that limit cell growth but operate via various pathways can work in concert with one another. $15.7M / Series B / Apr 28, 2022

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
EdTech
Hospitality
Consumer
Artificial Intelligence
Local
Platforms
Travel
Enterprise Software
InsurTech
Cryptocurrency
Oil and Gas
Retail
Social Impact
SaaS
Film
Restaurants
Payments
Photography
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Blockchain
Facebook
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Software
Crowdfunding
Venture Capital
Theatre
Recruiting
Web3
Medical
Fashion
LGBT
Beauty
Social
Infrastructure
Mobile Apps
Wine and Spirits
Food and Beverage
Publishing
Life Science
Cannabis
Climate
Music
Celebrity
Digital Media
FinTech
Manufacturing
Sporting Goods
Finance
Financial Services
Social Media
Real Estate
Franchise
Mobile Advertising
Non Profit
Internet
Art
Android
Biotech
Sustainability
Enterprise
Transportation
Proptech
Impact
Community
Hardware
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Gibraltar
Brazil
Egypt
Kyrgyzstan
Zambia
Singapore
Zimbabwe
Sweden
Oceania
Taiwan
LATAM
Norway
Liberia
Tajikistan
Tunisia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Isle of Man
Iran
Madagascar
Pakistan
Romania
Lesotho
Guernsey
Oman
Poland
Puerto Rico
Cameroon
Andorra
Sudan
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mauritius
Mozambique
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
Ireland
South Africa
France
Georgia
Ghana
Denmark
Iraq
Latvia
Mali
Malaysia
Rwanda
Philippines
Portugal
Sierra Leone
Senegal
El Salvador
Tanzania
India
United States
Germany
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Argentina
Bangladesh
Spain
Barbados
Belgium
Angola
Europe
Austria
Ethiopia
Jordan
Cyprus
Azerbaijan
Bulgaria
Ecuador
Estonia
Bolivia
Belize
Algeria
Italy
Faroe Islands
Jersey
Finland
Bahrain
Belarus
Hungary
Bahamas
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does BMI KOREA invest in?

BMI KOREA invests primarily in Medical, Biotechnology and Pharmaceutical startups, most often at Series B and Seed stage. Most of the 3 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did BMI KOREA last invest?

The most recent investment recorded for BMI KOREA closed in Mar 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
BMI KOREA BMI KOREA Find emails